Detalhe da pesquisa
1.
Comparison of four value sets derived using different TTO and DCE approaches: application to the new region-specific PBM, AP-7D.
Health Qual Life Outcomes
; 22(1): 16, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341575
2.
Gradient Boosted Tree Approaches for Mapping European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Onto 5-Level Version of EQ-5D Index for Patients With Cancer.
Value Health
; 26(2): 269-279, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096966
3.
Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L.
Health Qual Life Outcomes
; 21(1): 3, 2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650539
4.
Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes.
Clin Exp Nephrol
; 27(9): 728-736, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195388
5.
Comparison of physicians' and dentists' incident reports in open data from the Japan Council for Quality Health Care: a mixed-method study.
BMC Oral Health
; 23(1): 67, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732783
6.
Japanese preference weights of the Adult Social Care Outcomes Toolkit for Carers (ASCOT-Carer).
Qual Life Res
; 31(7): 2143-2151, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020110
7.
Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial.
Qual Life Res
; 31(6): 1829-1836, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34982354
8.
Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings.
Value Health
; 24(8): 1193-1202, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372985
9.
Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A).
Jpn J Clin Oncol
; 51(3): 498-503, 2021 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438717
10.
What Is a Valid Mapping Algorithm in Cost-Utility Analyses? A Response From a Missing Data Perspective.
Value Health
; 23(9): 1218-1224, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32940240
11.
Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System.
Value Health
; 23(1): 43-51, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952673
12.
Response Shift-Adjusted Treatment Effect on Health-Related Quality of Life in a Randomized Controlled Trial of Taxane Versus S-1 for Metastatic Breast Cancer: Structural Equation Modeling.
Value Health
; 23(6): 768-774, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32540235
13.
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
Health Qual Life Outcomes
; 18(1): 354, 2020 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33143687
14.
Development of Japanese utility weights for the Adult Social Care Outcomes Toolkit (ASCOT) SCT4.
Qual Life Res
; 29(1): 253-263, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31485915
15.
Incident reports involving hospital administrative staff: analysis of data from the Japan Council for Quality Health care nationwide database.
BMC Health Serv Res
; 20(1): 1054, 2020 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213455
16.
Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan.
Int J Technol Assess Health Care
; 36(3): 270-276, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32419677
17.
Japanese translation and cross-cultural validation of the Adult Social Care Outcomes Toolkit (ASCOT) in Japanese social service users.
Health Qual Life Outcomes
; 17(1): 59, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975154
18.
To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period?
Int J Clin Oncol
; 24(4): 350-358, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392116
19.
Exploring the Application of Cost-Effectiveness Evaluation in the Japanese National Health Insurance System.
Int J Technol Assess Health Care
; 35(6): 452-460, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30894242
20.
Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer.
Oncology
; 94(2): 107-115, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29145211